Posted in Other about 24 hours ago.
Job title: Head aT1D Early Detection Strategy and Partnerships
Location: Cambridge, MA, Bridgewater, NJ- hybrid
About the Job
At Sanofi, we are driven by one purpose - we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We never settle and now we are creating a new paradigm with a first-in-class therapy in Autoimmune Type 1 Diabetes (aT1D), which aims to delay the onset of Stage 3 aT1D. The onset of Stage 3 aT1D can have a major impact for patients and caregivers, including eventually needing insulin for the rest of their lives. What delayed onset means is more time for patients and caregivers to continue to live without the daily challenges of Stage 3 aT1D, including daily use of insulin and monitoring. It gives families and healthcare professionals more time to prepare care plans for a later diagnosis.
Sanofi recognizes that early detection of aT1D and risk factors for developing aT1D could improve health outcomes for T1D patients. But many are unaware they are at risk of developing T1D, which highlights the important public health benefits associated with screening - as certain patients who are screened may potentially be appropriate for therapy upon further testing and consultation with their HCP. Detecting aT1D early can prevent years of moderately elevated blood sugar levels and also potentially reduce the risk of going through Diabetic KetoAcidosis ("DKA"), which is a serious complication of diabetes that can lead to hospitalization and be life-threatening. Undiagnosed aT1D can be fatal - and early detection can save lives. It is therefore critical that people be proactively screened to help identify their risk for aT1D, before symptoms appear. This is where you come in.
We now present an exciting opportunity for you to go further faster. If you're excited by the prospect of helping to expand appropriate patient access to autoantibody screening tests, then we want to hear from you as we have built a great team to facilitate increased aT1D screening for appropriate patients, allowing for early detection, education, and treatment.
This is a chance to bring your strategic experience, curiosity, problem-solving skills, exceptional people and cross functional leadership energy and expertise to a truly transformative and career-defining leadership role where you can help change countless lives. In return, you will have a rare opportunity in pharma - the chance to help disrupt and delay a debilitating and widespread disease.
This role is critical within the US aT1D team and a key strategic contributor and influencer; this role reports to the Head of the aT1D business in the US, and offers you executive level visibility, dynamic and fast paced challenges, ability to accelerate business transformation and healthcare for patients. You will also partner with key 3rd party screening infrastructure players on strategic opportunities.
Innovation, patient focus and disruptive thinking are all key threads of our Play To Win culture.
We are seeking a highly strategic, motivated, and visionary leader interested in shaping the early identification of people at risk of developing autoimmune Type 1 Diabetes (aT1D). This individual will be responsible for leading the development and coordinating the implementation of the US strategy for accelerated aT1D screening across all stakeholders.
They will be expected to collaborate and communicate effectively in a matrix organization with significant interactions with Brand Marketing, Sales, Medical, Market Access, Market Research, Finance, Analytics, Business Operations and Senior Leadership. This role will report to the Head of the aT1D Business in the US and sit on the leadership team.
We are an innovative global healthcare company with a focus on immunology that extends to innovation in diabetes and transplant medicine. Across different countries, our talented teams are determined to deliver a best-in-class customer experience using the best of digital, artificial intelligence and personal know-how. With a focus on immunology that extends to innovation in diabetes and transplant medicines, we pursue progress to make a real impact on millions of patients around the world.
Main Responsibilities
:
Henderson Scott US |
Sanofi |
Adams and Associates
$21.80 per hour
|
Adams and Associates
$18.45 per hour
|
Adams and Associates
$60,000.00 per year
|